Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maribel Diaz-Ricart

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Atherosclerosis|January 17, 2020
Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicityDidac Jerez-Dolz, Sergi Torramade-Moix, Marta Palomo, et al.
Thrombosis and Haemostasis|December 7, 2017
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling PathwaysIrene Lopez-Vilchez, Didac Jerez-Dolz, Maribel Diaz-Ricart, et al.
Plos One|November 19, 2013
Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodGines Escolar, Victor Fernandez-Gallego, Eduardo Arellano-Rodrigo, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2020
Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?"Edward Richardson, Carmelo Carlo-Stella, Ruben Jara, et al.
Translational Oncology|October 16, 2025
Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasmsBlanca De Moner, Julia Martinez-Sanchez, Silvia Escribano-Serrat, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 11, 2023
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case seriesMarta Albanell-Fernández, Inés Monge-Escartín, Esther Carcelero-San Martín, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2014
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human bloodGines Escolar, Eduardo Arellano-Rodrigo, Irene Lopez-Vilchez, et al.
Frontiers in Immunology|December 8, 2022
Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies developmentAna Belén Moreno-Castaño, María Queralt Salas, Marta Palomo, et al.
Journal of Clinical Medicine|March 10, 2022
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous ThromboembolismMarina Canyelles, Melania Plaza, Noemí Rotllan, et al.
Journal of Cellular and Molecular Medicine|April 5, 2023
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid responseJulia Martinez-Sanchez, Marta Palomo, Alexandra Pedraza, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Atherosclerosis|January 17, 2020
Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicityDidac Jerez-Dolz, Sergi Torramade-Moix, Marta Palomo, et al.
Thrombosis and Haemostasis|December 7, 2017
Escitalopram Impairs Thrombin-Induced Platelet Response, Cytoskeletal Assembly and Activation of Associated Signalling PathwaysIrene Lopez-Vilchez, Didac Jerez-Dolz, Maribel Diaz-Ricart, et al.
Plos One|November 19, 2013
Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human bloodGines Escolar, Victor Fernandez-Gallego, Eduardo Arellano-Rodrigo, et al.
Journal of Thrombosis and Haemostasis : JTH|August 30, 2020
Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?"Edward Richardson, Carmelo Carlo-Stella, Ruben Jara, et al.
Translational Oncology|October 16, 2025
Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasmsBlanca De Moner, Julia Martinez-Sanchez, Silvia Escribano-Serrat, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 11, 2023
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case seriesMarta Albanell-Fernández, Inés Monge-Escartín, Esther Carcelero-San Martín, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2014
Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates – in vitro studies with steady and circulating human bloodGines Escolar, Eduardo Arellano-Rodrigo, Irene Lopez-Vilchez, et al.
Frontiers in Immunology|December 8, 2022
Early vascular endothelial complications after hematopoietic cell transplantation: Role of the endotheliopathy in biomarkers and target therapies developmentAna Belén Moreno-Castaño, María Queralt Salas, Marta Palomo, et al.
Journal of Clinical Medicine|March 10, 2022
TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous ThromboembolismMarina Canyelles, Melania Plaza, Noemí Rotllan, et al.
Journal of Cellular and Molecular Medicine|April 5, 2023
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid responseJulia Martinez-Sanchez, Marta Palomo, Alexandra Pedraza, et al.
Pageof 9